A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift that’s on par with major technological breakthroughs. A transformation that ...
A new Special Communication published Oct. 13, 2025, in JAMA outlines how the health care sector should responsibly seize the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback